Serum lipidomic study of long-chain fatty acids in psoriasis patients prior to and after anti-IL-17A monoclonal antibody treatment by quantitative GC‒MS analysis with in situ extraction

Table 4 Linear mixed model analysis of LCFAs (W8 vs. PSV)

	Measure	Estimate	Std. Err	t value	Pr ( >\|t\|)
LCFAs	Anti-IL-17A mAb treatment	-0.198	0.008	-23.971	0.000***
LCFAs	BMI	0.001	0.001	0.702	0.493
SFAs	Anti-IL-17A mAb treatment	-0.205	0.005	-42.579	0.000***
SFAs	BMI	0.001	0.001	0.739	0.472
MUFAs	Anti-IL-17A mAb treatment	0.134	0.041	3.27	0.003**
MUFAs	BMI	-0.001	0.006	-0.055	0.956
PUFAs	Anti-IL-17A mAb treatment	-0.129	0.026	-4.859	0.000***
PUFAs	BMI	-0.003	0.005	-0.617	0.544

ISSN: 1476-511X